Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery

Thimmaraju D R
Thimmaraju D R
Dr. Abdul Nasir Kurnool
Dr. Abdul Nasir Kurnool
Adichunchanagiri College of Pharmacy

Send Message

To: Author

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery

Article Fingerprint

ReserarchID

PDDTMAW206

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

Abstract

The present proniosomal gel investigation was aimed to minimize the adverse effects associated with present topical butenafine hydrochloride formulations and made to enhance its bioavailability and sustained release by novel proniosomal drug delivery system. Butenafine hydrochloride is an allylamine class of advanced antifungal drug. Which mainly recommended to treat long term topical fungal infection. Proniosomes were prepared by slurry method using different concentrations of non-ionic surfactant (span and tween) and evaluated various parameter like surface morphology, entrapment efficiency, drug content, viscosity, drug content, in-vitro % drug release, in-vitro fungal activity and stability studies. The results showed that formulation (F3) containing span 60: cholesterol (1:2) showed highest drug content (99.13%) and entrapment efficiency (79.87%) compared to other formulations. The pH and viscosity of prepared all proniosomal gel formulation were found in range (5.40-6.11) and (8920-14400CPs) correspondingly.

References

22 Cites in Article
  1. K Kumar,A Rai (2011). Development and evaluation of proniosomes as a promising drug carrier to improve transdermal drug delivery.
  2. S Poojary (2017). Topical antifungals: A review and their role in current management of dermatophytoses.
  3. Vineet Mathur,Yamini Satrawala,Mithunsingh Rajput (2014). Physical and chemical penetration enhancers in transdermal drug delivery system.
  4. P Lam,K Lee,R Wong,G Cheng,Z Bian,C Chui,R Gambari (2018). Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns.
  5. Shivani Verma,Puneet Utreja (2019). Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy.
  6. Indu Kaur,Shilpa Kakkar (2010). Topical delivery of antifungal agents.
  7. M Rao,P Kamble (2018). Formulation and evaluation of antifungal proniosomal gel for oral candidiasis.
  8. Shitalamin Poojary (2017). Topical antifungals: A review and their role in current management of dermatophytoses.
  9. G Kumar,P Rajeshwarrao (2011). Nonionic surfactant vesicular systems for effective drug delivery-an overview.
  10. A Gupta (2002). Butenafine: an update of its use in superficial mycoses.
  11. Ganapathi Bomma,Srimathkandala Harika,Ananthula Babu,Vasudha Bakshi (2017). Formulation Development and Evaluation of Proniosomal Powder of Candesartan.
  12. Ebtsam M Abdou,Noha M Ahmed (2016). Terconazole Proniosomal Gels: Effect of Different Formulation Factors, Physicochemical and Microbiological Evaluation.
  13. Ebtsam M Abdou,Noha M Ahmed (2016). Terconazole Proniosomal Gels: Effect of Different Formulation Factors, Physicochemical and Microbiological Evaluation.
  14. P Salve (2011). Development and evaluation of topical drug delivery system for terbinafine hydrochloride using niosomes.
  15. A Gurrapu,R Jukanti,S Bobbala,S Kanuganti,J Jeevana (2012). Improved oral delivery of valsartan from maltodextrin based proniosome powders.
  16. Gyati Shilakari Asthana,Abhay Asthana,Davinder Singh,Parveen Sharma (2016). Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation.
  17. S Desai,A Doke,J Disouza,R Athawale (2011). Development and evaluation of antifungal topical niosomal gel formulation.
  18. D-A Balch,Rosemarie Cooke (1970). A STUDY OF THE COMPOSITION OF HEN'S EGG-SHELL MEMBRANES.
  19. Hanan El-Laithy,Omar Shoukry,Laila Mahran (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies.
  20. S Desai,A Doke,J Disouza,R Athawale (2011). Development and evaluation of antifungal topical niosomal gel formulation.
  21. T Yoshioka,B Sternberg,A Florence (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85).
  22. Monica Rao,Priyanka Kamble (2018). FORMULATION AND EVALUATION OF ANTIFUNGAL PRONIOSOMAL GEL FOR ORAL CANDIDIASIS.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Thimmaraju D R. 2020. \u201cProniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 20 (GJMR Volume 20 Issue B5).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-B Classification NLMC Code: QV 252
Version of record

v1.2

Issue date
July 27, 2020

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2310
Total Downloads: 1109
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Proniosomal Gel: Formulation and Charecterization of an Antifungal Drug (Butenafine HCL) Loaded Proniosomes for Topical Delivery

Thimmaraju D R
Thimmaraju D R <p>Adichunchanagiri College of Pharmacy</p>
Dr. Abdul Nasir Kurnool
Dr. Abdul Nasir Kurnool

Research Journals